Impact of Extensive HbA1c Control on Major Microvascular Complications in Type 2 Diabetes Mellitus with Short Duration of Disease

被引：0
|
作者：
Tavakoli, Mitra
Ishibashi, Fukashi
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-557-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
557-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] HbA1c and microvascular complications in type 1 diabetes
    Pavlicek, Vojtech
    DIABETOLOGIE, 2023, 19 (01): : 79 - 80
  • [2] Impact of normalised HbA1c on diabetic neuropathy and other microvascular complications in Type 2 diabetes
    Tavakoli, M.
    Ishibashi, F.
    DIABETIC MEDICINE, 2019, 36 : 93 - 93
  • [3] Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
    Bejan-Angoulvant, T.
    Cornu, C.
    Archambault, P.
    Tudrej, B.
    Audier, P.
    Brabant, Y.
    Gueyffier, F.
    Boussageon, R.
    DIABETES & METABOLISM, 2015, 41 (03) : 195 - 201
  • [4] Type 2 diabetes mellitus: Link between diet, HbA1c and complications
    Sami, Waqas
    Ansari, Tahir
    Butt, Nadeem Shafique
    Ab Hamid, Mohd Rashid
    AUSTRALASIAN MEDICAL JOURNAL, 2016, 9 (09): : 346 - 356
  • [5] THE IMPACT OF BASELINE HBA1C AND HBA1C TRAJECTORIES ON TIME TO THERAPY ESCALATION IN TYPE 2 DIABETES MELLITUS
    McEwan, P.
    Foos, V
    Larnotte, M.
    VALUE IN HEALTH, 2015, 18 (07) : A698 - A698
  • [6] Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus
    Wu, Tzu-En
    Su, Yu-Wen
    Chen, Harn-Shen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [7] Impact of HbA1c and sulfonylurea use on hypoglycaemia in type 2 diabetes mellitus
    Clements, K.
    Bron, M.
    Taylor, D.
    Emptage, N.
    Hudgens, S.
    Dabbous, O.
    DIABETOLOGIA, 2010, 53
  • [8] Impact of HbA1c and Sulfonylurea Use on Hypoglycemia in Type 2 Diabetes Mellitus
    Bron, Morgan
    Clements, Karen
    Taylor, Doug
    Emptage, Nicholas
    Hudgens, Stacie
    Dabbous, Omar
    DIABETES, 2010, 59 : A207 - A208
  • [9] Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus
    Wilding, John P. H.
    Blonde, Lawrence
    Leiter, Lawrence A.
    Cerdas, Sonia
    Tong, Cindy
    Yee, Jacqueline
    Meininger, Gary
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (03) : 438 - 444
  • [10] Glycaemic efficacy of canaglilozin by baseline HbA1c and known duration of type 2 diabetes mellitus
    Cerdas, S.
    Leiter, L. A.
    Blonde, L.
    Wilding, J.
    Tong, C.
    Yee, J.
    Meininger, G.
    DIABETOLOGIA, 2014, 57 : S344 - S344
12345